1Dessain SK,Yu H,Reddel RR,et al.Methylation of the human telomerase gene CpG isIand [J].Cancer Res,2000,60(3):537.
2Gunes C,Lichtsteiner S.Expression of the hTERT gene is regulated at the level of transcriptional initiation and repressed by Mad1[J].Cancer Res,2000,60(8):2116.
3Horikawa I,Cable PL, Mshari C,et al.Cloning and characterization of the promoter region of human telomerase reverse transcfiptase gene [J].Cancer Res, 1999,59:826.
4Komata T, Kondo Y,Kanzawa T,et al.Caspase-8 gene therapy using the human telomerase reverse transcfiptase promoter for malignant glioma cells [J].Hum Gene Ther,2002,13(9):1015.
5Painter RG, I.anson NA Jr, Jin Z,et al.Conditional expression of a suicide gene by the telomere reverse transcfiptase promoter for potential post-therapeutic deletion of tumorigenesis [J].Cancer Sci,2005,96(9):607.
8Song JS.Activity of the human telomerase catalytic subunit (hTERT)gene promoter could be increased by the SV40 enhancer [J]. Biosci Biotechnol Biochem,2004,68(8): 1634.
1Teiji T, Hidehumi I, Masanori M, et al. Tumor-specific gene therapy for undifferentiated thyroid carcinoma utilizing the telomerase reverse transcriptase promoter. J Clin Endocrinol Metab, 2003, 88 : 3531-3538.
2Okada T, Caplen N J, Ramsey WJ, et al. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo. J Gene Med ,2004,6:288-299.
3Kubo H,Gardner TA, Wada Y, et al. Phase I dose escalation clinical trial of adenovirus vector carrying osteocalcin promoter-driven herpes simplex virus thymidine kinase in localized and metastatic hormonerefractory prostate cancer. Hum Gene Ther,2003 ,14 :227-241.
4Mohr L, Shankara S, Yoon SK, et al. Gene therapy of hepatocellular carcinoma in vitro and in vivo in nude mice by adenoviral transfer of the Eschefichia coli pufine nucleoside phosphorylase gene. Hepatology,2000,31:607-614.
5Mah C, Byrne B J, Flotte TR. Virus-based gene delivery systems. Clin Pharmacokinet ,2002,41:901-911.
6Hiem R,Cubitt AB, Tsien RY. Improved green fluorescence. Nature,1995,373 : 663 -664.
7Kirch HC, Ruschen S, Brockmann D, et al. Tumor-specific activation of hTERT-derived promoters by tumor suppressive E1A-mutants involves recruitment of p300/CBP/HAT and suppression of HDAC-1 and defines a combined tumor targeting and suppression system. Oneogene ,2002,21:7991-8000.
8Song JS.Activity of the human telomerase catalytic subunit(h-TERT) gene promoter could be increased by the SV40 enha-ncer[J].Biosci Biotechnol Biochem,2004,68(8):1634-1639.
9Takakura M,Kyo S,Kanaya T,et al.Cloning of human telome-rase catalytic subunit(hTERT) gene promoter and identifica-tion of proximal core promoter sequences essential for transcri-ptional activation in immortalized and cancer cells[J].Cancer Res,1999,59(3):551-557.
10Komata T,Kondo Y,Kanzawa T,et al.Treatment of malignant glioma cells with the transfer of constitutively active caspase-6 using the human telomerase catalytic subunit(human telomerase reverse transcriptase) gene promoter[J].Cancer Res,2001,61(15):5796-5802.
